期刊文献+

心脏超声Tei指数监测妊娠伴肺动脉高压患者心功能的临床分析 被引量:1

下载PDF
导出
摘要 目的探讨心脏多普勒超声Tei指数监测妊娠伴肺动脉高压患者心功能的临床应用价值。方法观察妊娠合并心脏病患者28例,分别设为肺动脉高压组(14例)和非肺动脉高压组(14例);另外正常妊娠妇女作为对照组(15例),分别测量三组左心室及右心室Tei指数,左、右心室等容舒张时间(IRT)及等容收缩时间(ICT),左、右心室射血时间(ET)。结果肺动脉高压组右心室Tei指数明显高于对照组和非肺动脉高压组(P<0.05或P<O.01);肺动脉高压组右心室IRICT较对照组和非肺动脉高压组均明显延长(P<0.05或P<O.01);肺动脉高压组左心室IRT长于对照组和非肺动脉高压组(P<0.01);肺动脉高压组右心室ET较对照组和非肺动脉高压组均缩短(P<0.05或P<0.01)。肺动脉高压组左心室ET短于对照组和非肺动脉高压组P<0.05)。结论 Tei指数是监测妊娠合并肺动脉高压患者左、右心室功能简便而准确的超声指标,Tei指数可以评估疾病的严重程度,预测心功能的优劣。
作者 赵静 苏世军
出处 《宁夏医科大学学报》 2013年第12期1391-1393,共3页 Journal of Ningxia Medical University
  • 相关文献

参考文献6

  • 1Rubin LJ. Pulmonary arterial hypertension[J].{H}PROCEEDINGS OF THE AMERICAN THORACIC SOCIETY(PATS),2006.111-115.
  • 2赵美丽,陈松旺.Tei指数对肺动脉高压患者右心室功能的研究[J].中国超声诊断杂志,2006,7(6):413-415. 被引量:21
  • 3Weiss BM,Hess OM. Pulmonary vascular disease and pregnancy:current controversies,management strategise,and perspectives[J].{H}EUROPEAN HEART JOURNAL,2000.104-115.
  • 4Badesch DB,Abman SH,Sirmonneau G,et a1. Medieal therapy for pulmonary arterial hypertension:updated ACCP evidence-Based elinical practice guidelines[J].{H}CHEST,2007.1917-1928.
  • 5Wu ET,Akagi T,Taniguchi M. Differences in right and left ventricular remodeling after transcatheter closure of atrial septal defect among adults[J].Catheter Cardiovasc Lnterv,2007.866-871.
  • 6程蕾蕾,舒先红,葛均波.一种综合评价心脏收缩和舒张功能的新指数—Tei指数[J].中国超声医学杂志,2003,19(2):156-160. 被引量:34

二级参考文献35

  • 1Eidem BW, O'Leary PW, Tei C, et al. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease. Am J Cardiol,2000,86(6) :654-658
  • 2Tei C,Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiography, 1996,9: 838-847
  • 3Eidem BW, Tei C, O'Leary PW, et al. Nongeometric quantitative assessment of right and left ventricular function., myocardial performance index in normal children and patients with Ebstein anomaly. J Am Soc Echocardiogr, 1998,11 (9) .. 849-856
  • 4Tei C,Ling LH,Hodge DO ,et al. New index of combined systolic and diastolic myocardial performance:a simple and reproducible measure of cardiac function .a study in normals and dilated cardiomyopathy. J Cardiol, 1995,26 (6), 357-366
  • 5Yeo TC,Dujardin KS, Tei C,et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol, 1998,81(9):1157-1161
  • 6Yakabe K;Ikeda S;Naito T.Left ventricular mass and global function in essential hypertension after antihypertensive therapy,2000(01).
  • 7Kim WH;Otsuji Y;Seward JB.Estimation of left ventricular function in right ventricular volume and pressure overload. Detection of early left ventricular dysfunction by Tei index[J],1999(02).
  • 8Eidem BW;O'Leary PW;Tei C.Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease,2000(06).
  • 9Eidem BW;Tei C;O'Leary PW.Nongeometric quantitative assessment of right and left ventricular function: myocardial performance index in normal children and patients with Ebstein anomaly[J],1998(09).
  • 10Cohn PF;Gorlin R;Collins JJ Jr.Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease,1974.

共引文献52

同被引文献26

  • 1Simonneau G, Robhins I M, Beghetti M, et al.Updated clinical classification of pulmonary hypertension[J].J Am Coll Cardiol, 2009, 54(1 Suppl): S43-54.
  • 2Morrcll N W, Adnot S, Archer S L, et al.Cellular and molecular basis of pulmonary arterial hypertension[J].J Am Cull Cardiol, 2009, 54(1 Suppl): S20-31.
  • 3Ma J, Zhang L, Han W, et al.Activation of JNK/c-Jun is required for the prnliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells[J].J Lipid Res, 2012, 53(6): 1093-1095.
  • 4Cunningham F G, John C H.WILLIAMS OBSTETRICS[M].22nd Ed.New York: the McGraw-Hill Companies, 2005 : 1017-1042.
  • 5George K, Lui M D, Candice K, et al.Heart rate ~sponse during exercise and pregnancy outcome in women with congenital heart disease[J].Circ J, 2011, 123(3): 242-248.
  • 6Shinji K, Kaoru Y.Maternal outcome in pregnancy complicated with pulmonary arterial hypertension[J].Circ J, 2012, 76(9): 2249-2254.
  • 7Siu S C, Sermer M, Harrison D A, et al.Risk and predictors for pregnancy-related complications in women with heart disease[J].Circ J, 1997, 96(9): 2789-2794.
  • 8Tanous D, Siu S C.B-type natriuretic peptide in pregnant women with heart disease[J].J Am Coll Cardiol, 2010, 56(15): 1247-1253.
  • 9Voelkel M A, Wynne K M, Badesch D B, et al.Hyperurieemia in severe pulmonary hypertension[J].Chest, 2000, 117(1) : 19-24.
  • 10Geohas C, McLaughlin V V.Successful management of pregnancy in a patient with Eisenmenger Syndrome with epoprostenul[J].Chest, 2003, 124(3): 1170-1173.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部